Skip to main content

Table 1 The routine immunization schedule recommended in the UK during the study period

From: A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants

Vaccine Trade name and manufacturer Recommended age at vaccination (months)
DTaP3-IPV-Hib Infanrix-IPV-Hib, GSK 2, 3, 4
Meningococcal serogroup B Bexsero, GSK 2, 4, 12
13-valent pneumococcal conjugate Prevenar13, Pfizer 2, 4, 12
Oral live attenuated rotavirus Rotarix, GSK 2, 3
Meningococcal serogroup C conjugate NeisVac-C, GSK 3
Hib-MenC Menitorix, GSK 12
Measles-mumps-rubella (MMR) Priorix, Sanofi Pasteur 12
  1. Abbreviations: DTaP3-IPV diphtheria, tetanus, acellular pertussis (three pertussis antigens, 25 μg each of pertussis toxoid and filamentous haemagglutinin and 8 μg of pertactin), inactivated poliovirus, Haemophilus influenzae type B, IPV inactivated poliovirus, Hib Haemophilus influenzae type b, MenC meningococcal serogroup C, GSK GlaxoSmithKleine